HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Retrolaminar block: analgesic efficacy and safety evaluation.

AbstractPURPOSE:
Retrolaminar block (RLB) is a thoracic truncal block that can produce analgesia for the thoracic and abdominal wall. However, the characteristics of RLB are not well known. The aim of this study was to determine analgesic efficacy by measuring postoperative consume of patient-controlled analgesia (PCA), additional nonsteroidal antiinflammatory drug (NSAID) rescue, and opioid rescue. Our secondary analysis included assessment of the chronological change in arterial levobupivacaine concentrations after the block.
METHODS:
This prospective, randomized, double-blinded study included 30 patients scheduled for modified radical mastectomy under general anesthesia. The patients were randomized to receive either a landmark-guided RLB or paravertebral block (PVB) catheter placement on T4. Continuous infusion with 4 ml/h of 0.25 % levobupivacaine was started for 72 h, after initial injection of 20 ml 0.375 % levobupivacaine before surgery. Postoperative pain was compared using the amount of block PCA (3 ml 0.25 % levobupivacaine with 30-min lockout), NSAID, and opioid rescue. Arterial blood was sampled for 120 min after the initial injection.
RESULTS:
The frequency of postoperative block PCA use was significantly high after RLB in 24 h [p = 0.01; 6 (3-12) vs. 2.5 (0.3-3) times, respectively]. There was no PCA use after 24 h in either group. There was no postoperative opioid rescue use throughout the study. After RLB and PVB, there was no significant difference in T max (p = 0.14; 15 ± 8 vs. 15 ± 8 min, respectively) and C max (p = 0.2; 0.9 ± 0.2 vs. 0.9 ± 0.3 µg/ml, respectively), and all the concentrations were below the threshold of local anesthetic systemic toxicity.
CONCLUSION:
Continuous RLB was not inferior to PVB except for the first 24 h, and was satisfactory after mastectomy. RLB showed safe, low peak arterial levobupivacaine concentrations.
AuthorsTakeshi Murouchi, Michiaki Yamakage
JournalJournal of anesthesia (J Anesth) Vol. 30 Issue 6 Pg. 1003-1007 (12 2016) ISSN: 1438-8359 [Electronic] Japan
PMID27518726 (Publication Type: Journal Article, Randomized Controlled Trial)
Chemical References
  • Analgesics
  • Analgesics, Opioid
  • Anti-Inflammatory Agents, Non-Steroidal
  • Levobupivacaine
  • Bupivacaine
Topics
  • Aged
  • Analgesia, Patient-Controlled (methods)
  • Analgesics (administration & dosage)
  • Analgesics, Opioid (therapeutic use)
  • Anesthesia, General
  • Anti-Inflammatory Agents, Non-Steroidal (therapeutic use)
  • Bupivacaine (administration & dosage, analogs & derivatives)
  • Double-Blind Method
  • Female
  • Humans
  • Levobupivacaine
  • Mastectomy, Modified Radical (methods)
  • Middle Aged
  • Nerve Block (methods)
  • Pain, Postoperative (drug therapy)
  • Prospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: